Pregnancy Interaction

• Ivermectin is typically not advised during pregnancy, particularly in the first trimester, due to limited safety data available for humans.
• Animal investigations have indicated potential fetal harm at elevated doses.
• Utilize solely when the potential benefits surpass the risks and under the guidance of a qualified medical professional.
• If you are pregnant, planning to become pregnant, or currently breastfeeding, please consult your healthcare professional prior to using EVIMECTIN-6 DT.

Expert advice

• Take EVIMECTIN-6 DT on an empty stomach with a full glass of water.
• Refrain from consuming food for at least two hours prior to and following the administration of the dose to ensure optimal absorption.
• Maintain proper hygiene and cleanse hands frequently to prevent reinfection.
• Refrain from consuming alcohol and high-fat foods while undergoing treatment.
• If symptoms continue following treatment, a subsequent stool or parasite examination may be required.
• Consult a healthcare professional prior to administering to children weighing less than 15 kg.

Side Effects

• Nausea, emesis, or diarrhea
• Dizziness or headache
• Muscular discomfort or fatigue
• Cutaneous dermatitis or pruritus
• Slight fever

Uncommon but severe:

• Facial or extremity swelling
• Dyspnea or chest discomfort
• Severe anaphylactic responses
• In the event of any serious adverse reactions, cease use immediately and consult a healthcare professional without delay.

How it works

• Interaction with nerve and muscle cells of parasites.
• Inducing paralysis and eventual demise of the organisms.
• Effective in treating a broad spectrum of intestinal worms and external parasites such as scabies and fleas.
• It specifically targets parasites without impacting human cells, rendering it a selective and efficacious antiparasitic agent.

Medicine Interaction

• Other antiparasitic or deworming medications unless prescribed by a healthcare professional.
• Warfarin or anticoagulants, as they may elevate the risk of hemorrhaging.
• Sedatives or alcohol, which may elevate levels of drowsiness or vertigo.
• Medications that influence hepatic enzymes (e.g., carbamazepine, phenytoin).
• Always notify your physician of all current medications and supplements.

How to use

• Administer the tablet once as directed, typically as a single dose.
• Can be administered with or without water, as it is dispersible—dissolve in water prior to ingestion if desired.
• Refrain from crushing or breaking unless explicitly instructed.
• Ensure the dose is not missed. If overlooked, administer it promptly upon recalling.
• Do not administer a repeat dose unless explicitly advised by your physician.

Uses/Indications

• Intestinal parasitic infections (e.g., strongyloidiasis, ascariasis)
• Onchocerciasis (River Blindness)
• Scabies (mite infestation)
• Pediculosis capitis infestation
• Filariasis (when administered as part of combination therapy)
• Rosacea and specific dermatological conditions associated with Demodex insects

FAQs for medicine?

Q1. What is the purpose of EVIMECTIN-6 DT?

It is utilized for the treatment of various parasitic infections, including scabies, parasites, and intestinal worms.

Q2. Is it permissible to consume EVIMECTIN-6 DT on a daily basis?

No. It is typically administered as a single or occasional dose, based on the type of infection and the physician's recommendation.

Q3. Is it safe to use during breastfeeding?

Ivermectin is excreted into breast milk in minimal quantities. Use solely under the guidance of your physician.

Q4. Is EVIMECTIN-6 DT suitable for use in children?

Yes, but exclusively for minors exceeding 15 kg and under strict medical supervision.

Q5. Is it advisable to consume EVIMECTIN-6 DT with food?

It is most effective when consumed on an empty stomach.

Q6. What is the typical duration for it to take effect?

It begins to take effect within hours of administration, eliminating parasites over the subsequent days.

Q7. Is EVIMECTIN-6 DT capable of fully treating scabies?

Yes, but it typically necessitates one to two doses administered at a one-week interval, in conjunction with topical therapies and hygiene practices.